|
|
|
The Allergy, Asthma and Sinus Research Institute is an independent research organization under Dr. Steven’s direction. We participate in clinical trials of new medications and therapies for two reasons: 1. We believe it is important to do what we can to help bring new treatments for allergies and asthma to market; and 2. Many of our patients have severe symptoms that are only somewhat controlled with the medications that are currently on the market. By participating in this process, we are often able to offer our patients new drugs that may work much better or have fewer side effects. People interested in clinical research sometimes participate out of an interest to help others, but are most often looking to try new medications, because those that are available don’t control their symptoms well. Others enjoy the fact that they are helping to “push back the forefront” - helping out in the drug development process - and they appreciate being paid to do so. A stipend is provided to compensate you for the time that is required to participate in the study, including filling out diary cards, transportation to and from the clinic, etc. The payments typically range from $200 to as much as $4000, depending on how much time and effort is required by the study. Investigational medications are always provided at no cost to you, and all physical exams, blood work, lung function testing, and other procedures are performed free of charge. All study-related medication is provided at no cost during the trial, which can last anywhere from a few weeks to as long as a year, depending on the study. Dr. Steven has extensive experience in clinical trials, completing five or six studies per year since 1994, and earning the distinction as a Certified Physician Investigator through the Association of Clinical Research Professionals. This is awarded to physicians who strive to gather high quality data while paying rigorous attention to patient safety. Furthermore, since excellence in health care requires cooperation among all of your physicians, we always ask for your permission for us to share the results of study-related procedures with your primary care physician - such as X-rays, blood work, EKGs, lung function tests and any other procedures required by the study. We are currently conducting several trials of medications for asthma and allergic rhinitis - the congestion and sneezing found with allergies. To find out more about the studies that are currently enrolling, and to explore whether you might be eligible to participate in one of them, please call (414)529-8519. Our study coordinators, Jenny and Marie, will be happy to help you. studies@aasc-drsteven.com
Welcome to the TRUMPET Clinical Trial
This clinical trial is for subjects with severe and persistent asthma who are currently on high-dose, inhaled corticosteroid treatments.
For the longest time, you have used an inhaled corticosteroid therapy and may have experienced asthma symptoms only every now and then. And when symptoms did occur, you were able to use your inhaler to regain control.
But lately, your asthma symptoms have been occurring more frequently and you’re having a harder time keeping them under control.
The TRUMPET clinical trial hopes to find a more effective asthma treatment for people like you in the future. TRUMPET is evaluating an investigational drug and device combination called Fp Dry Powder Inhaler (DPI). Doctors want to learn more about the efficacy and safety of Fp DPI in subjects who are currently on corticosteroid treatments, but continue to experience severe and persistent, uncontrolled asthma.
By participating in TRUMPET, you or your child is making an important contribution to potentially one day finding more effective treatment options for asthma subjects.
Pediatric Asthma Research Study
Does your child have asthma?
Children may qualify if they:
· Are 4 to 11 years of age.
· Have had asthma for at least six months.
· Have had asthma bad enough to see a doctor in the last 12 months.
There are other study requirements that will determine whether your child may participate in this clinical research study.
· There is no placebo (sugar pill) in this clinical research study.
· There will be no blood draws (no needles) during this clinical research study.
· All study participants will receive asthma medication at no charge.
· Health insurance is not needed to participate.
For more information about this study contact:
Allergy, Asthma & Sinus Center (Jenny or Marie)
ALLERGY
DUST MITES AND THE ALLERGIES THEY CAUSE ARE IN EVERY ROOM.
SNEEZING? ITCHY EYES? STUFFY NOSE? THERE’S ROOM FOR YOU IN OUR RESEARCH STUDY.
Help us to test and investigational immunotherapy tablet for dust mite allergy. Participants may be eligible for this study if they are 12 years of age or older and have been taking allergy medications for dust mite allergy symptoms during the past year.
Medical history and other criteria will be reviewed at the first study visit, including a skin prick allergy test and blood test. The study lasts up to 2 years and requires 9 clinic visits. All study-related office visits, medical examinations, and investigational immunotherapy treatment will be provided at no cost to qualified participants.
Call today for more information: Jenny or Marie – 414.529.8519 or studies@myaasc.com
|
|